TY - JOUR
T1 - Design and in vitro evaluation of floating drug delivery system for an antipsychotic agent: A technical report
AU - Kar, M.
AU - Reddy, M.S.
N1 - Cited By :6
Export Date: 10 November 2017
CODEN: JPHTE
Correspondence Address: Kar, M.; Department of Pharmacy, Mohan Lal Sukhadia University, Udaipur 313001, India; email: [email protected]
Chemicals/CAS: carbamazepine, 298-46-4, 8047-84-5; Antipsychotic Agents; Carbamazepine, 298-46-4; Delayed-Action Preparations; Excipients
References: Khanna, S., Agrawal, P., Anticonvulsants in pregnancy and lactation (1997) Psychiatry Today, 1, pp. 39-41; Shastri, C., Aggrawal, A.K., Khandelwal, S.K., Bhashyam, V.S.P., Channabasavanna, Report from symposium on 'compliance issues in schizophrenia' (1997) Psychiatry Today, 1, pp. 53-64; Anand, V., Kandarapu, R., Garg, S., Ion Exchange resins: Carrying drug delivery forward (2001) Drug Del. Today, 6, pp. 910-911; Levy, R.H., Pitlick, W.H., Troupin, A.S., Pharmacokinetics of carbamazepine in normal man (1975) Clin. Pharmacol. Ther., 17 (6), pp. 657-658; Kobayashi, Y., Ito, S., Itai, S., Tamamato, K., Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate (2000) Int. J. Pharm., 193, pp. 137-146; Desai, S., Bolton, S., A floating controlled release drug delivery system, in vitro-in vivo evaluation (1993) Pharm. Res., 10, pp. 1321-1325; Wan, L.S.C., Heng, P.W.S., Wong, L.F., Matrix swelling; a simple model describing extent of swelling of HPMC matrices (1995) Int. J. Pharm., 116, pp. 159-168; Venkatesh Nath, B.S., Doddayya, H.R.S., Hydroxy propyl methyl cellulose as wicking agent in matrix tablets of cetyl alcohol (1999) Indian Drugs, 36, pp. 720-722; Giunchedi, P., Conte, U., La Manna, a swellable polymer as carbamazepine dissolution rate enhancer (1990) Boll. Chim. Farm., 129, pp. 17-20; Jimenez-Castellanos, R.M., Zia, H., Rhodes, T.C., Design and testing in-vitro of a bioadhesive and floating drug delivery system for oral application (1994) Int. J. Pharm., 105, pp. 65-70; Chaudary, R.S., Jindal, K.C., Khanna, S., Stability testing of pharmaceuticals (1994) The East. Pharm., 37, pp. 65-67; Fell, J.T., Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract (1996) Journal of Anatomy, 189 (3), pp. 517-519; Nur, A.O., Zhang, J.S., Captopril floating and/or bioadhesive tablets: Design and release kinetics (2000) Drug Dev. Ind. Pharm., 26, pp. 965-969
PY - 2006
Y1 - 2006
N2 - Floating drug delivery systems are used to target drug release in the stomach or to the upper parts of the intestine. The oral delivery of the anti-psychotic agent carbamazepine was facilitated by preparing a non-disintegrating floating dosage form which can increase its absorption in the stomach by increasing the drug's gastric residence time. The polymers used were HPMC (low and high viscosity), guar gum, and carbopol, along with sodium bicarbonate as the gas-generating agent. The prepared tablets were evaluated for their physicochemical properties and drug release. In vitro release studies indicated that the carbamazepine release from the floating dosage forms was uniform and followed a zero-order release. It was observed that the devices containing higher proportions of HPMC (high viscosity) showed slower release than those containing lower proportions while also maintaining the integrity of the device (≥24 h). The incorporation of guar gum helps to maintain the device's integrity, and due to its viscolysing property also affects the drug's release profile. Sodium bicarbonate which was used as the gas-generating agent causes the tablet to float for the required time (≥24 h).
AB - Floating drug delivery systems are used to target drug release in the stomach or to the upper parts of the intestine. The oral delivery of the anti-psychotic agent carbamazepine was facilitated by preparing a non-disintegrating floating dosage form which can increase its absorption in the stomach by increasing the drug's gastric residence time. The polymers used were HPMC (low and high viscosity), guar gum, and carbopol, along with sodium bicarbonate as the gas-generating agent. The prepared tablets were evaluated for their physicochemical properties and drug release. In vitro release studies indicated that the carbamazepine release from the floating dosage forms was uniform and followed a zero-order release. It was observed that the devices containing higher proportions of HPMC (high viscosity) showed slower release than those containing lower proportions while also maintaining the integrity of the device (≥24 h). The incorporation of guar gum helps to maintain the device's integrity, and due to its viscolysing property also affects the drug's release profile. Sodium bicarbonate which was used as the gas-generating agent causes the tablet to float for the required time (≥24 h).
M3 - Article
SN - 1079-7440
VL - 60
SP - 389
EP - 394
JO - PDA Journal of Pharmaceutical Science and Technology
JF - PDA Journal of Pharmaceutical Science and Technology
IS - 6
ER -